182 related articles for article (PubMed ID: 24058630)
21. Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene.
Wang Y; Krushel LA; Edelman GM
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3932-6. PubMed ID: 8632992
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of cell cycle regulators in phenotypic variants of transgenically induced bladder tumors: implications for tumor behavior.
Garcia-España A; Salazar E; Sun TT; Wu XR; Pellicer A
Cancer Res; 2005 Feb; 65(4):1150-7. PubMed ID: 15734997
[TBL] [Abstract][Full Text] [Related]
23. Organ-specific, carcinogen-induced increases in cell proliferation in p53-deficient mice.
Sukata T; Ozaki K; Uwagawa S; Seki T; Wanibuchi H; Yamamoto S; Okuno Y; Fukushima S
Cancer Res; 2000 Jan; 60(1):74-9. PubMed ID: 10646856
[TBL] [Abstract][Full Text] [Related]
24. Deficiency of pRb family proteins and p53 in invasive urothelial tumorigenesis.
He F; Mo L; Zheng XY; Hu C; Lepor H; Lee EY; Sun TT; Wu XR
Cancer Res; 2009 Dec; 69(24):9413-21. PubMed ID: 19951992
[TBL] [Abstract][Full Text] [Related]
25. Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis.
Mo L; Zheng X; Huang HY; Shapiro E; Lepor H; Cordon-Cardo C; Sun TT; Wu XR
J Clin Invest; 2007 Feb; 117(2):314-25. PubMed ID: 17256055
[TBL] [Abstract][Full Text] [Related]
26. Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation.
Zhang ZT; Pak J; Huang HY; Shapiro E; Sun TT; Pellicer A; Wu XR
Oncogene; 2001 Apr; 20(16):1973-80. PubMed ID: 11360181
[TBL] [Abstract][Full Text] [Related]
27. L-Leucine and L-isoleucine enhance growth of BBN-induced urothelial tumors in the rat bladder by modulating expression of amino acid transporters and tumorigenesis-associated genes.
Xie XL; Kakehashi A; Wei M; Yamano S; Takeshita M; Yunoki T; Wanibuchi H
Food Chem Toxicol; 2013 Sep; 59():137-44. PubMed ID: 23747718
[TBL] [Abstract][Full Text] [Related]
28. SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.
Ogawa S; Fukuda A; Matsumoto Y; Hanyu Y; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Yoshikawa T; Goto N; Hiramatsu Y; Tsuda M; Maruno T; Nakanishi Y; Hussein MS; Tsuruyama T; Takaori K; Uemoto S; Seno H
Gastroenterology; 2020 Aug; 159(2):682-696.e13. PubMed ID: 32360551
[TBL] [Abstract][Full Text] [Related]
29. A spatially and temporally restricted mouse model of soft tissue sarcoma.
Kirsch DG; Dinulescu DM; Miller JB; Grimm J; Santiago PM; Young NP; Nielsen GP; Quade BJ; Chaber CJ; Schultz CP; Takeuchi O; Bronson RT; Crowley D; Korsmeyer SJ; Yoon SS; Hornicek FJ; Weissleder R; Jacks T
Nat Med; 2007 Aug; 13(8):992-7. PubMed ID: 17676052
[TBL] [Abstract][Full Text] [Related]
30. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma.
Hartmann A; Moser K; Kriegmair M; Hofstetter A; Hofstaedter F; Knuechel R
Am J Pathol; 1999 Mar; 154(3):721-7. PubMed ID: 10079249
[TBL] [Abstract][Full Text] [Related]
31. Chromosomal imbalances in successive moments of human bladder urothelial carcinoma.
Nascimento e Pontes MG; da Silveira SM; Trindade Filho JC; Rogatto SR; Viana de Camargo JL
Urol Oncol; 2013 Aug; 31(6):827-35. PubMed ID: 21763161
[TBL] [Abstract][Full Text] [Related]
32. p53 mutation and loss have different effects on tumourigenesis in a novel mouse model of pleomorphic rhabdomyosarcoma.
Doyle B; Morton JP; Delaney DW; Ridgway RA; Wilkins JA; Sansom OJ
J Pathol; 2010 Oct; 222(2):129-37. PubMed ID: 20662002
[TBL] [Abstract][Full Text] [Related]
33. Adenovirus-mediated Cre deletion of floxed sequences in primary mouse cells is an efficient alternative for studies of gene deletion.
Prost S; Sheahan S; Rannie D; Harrison DJ
Nucleic Acids Res; 2001 Aug; 29(16):E80. PubMed ID: 11504888
[TBL] [Abstract][Full Text] [Related]
34. Antisense RNA-mediated reduction of p53 induces malignant phenotype in nontumorigenic rat urothelial cells.
Okamoto M; Hattori K; Fujimoto K; Tanaka Y; Gloosby CL; Oyasu R
Carcinogenesis; 1998 Jan; 19(1):73-9. PubMed ID: 9472696
[TBL] [Abstract][Full Text] [Related]
35. Characterization of Pdgfrb-Cre transgenic mice reveals reduction of ROSA26 reporter activity in remodeling arteries.
Cuttler AS; LeClair RJ; Stohn JP; Wang Q; Sorenson CM; Liaw L; Lindner V
Genesis; 2011 Aug; 49(8):673-80. PubMed ID: 21557454
[TBL] [Abstract][Full Text] [Related]
36. Constitutive β-catenin activation induces male-specific tumorigenesis in the bladder urothelium.
Lin C; Yin Y; Stemler K; Humphrey P; Kibel AS; Mysorekar IU; Ma L
Cancer Res; 2013 Oct; 73(19):5914-25. PubMed ID: 23928991
[TBL] [Abstract][Full Text] [Related]
37. Selective binding of lectins to normal and neoplastic urothelium in rat and mouse bladder carcinogenesis models.
Zupančič D; Kreft ME; Romih R
Protoplasma; 2014 Jan; 251(1):49-59. PubMed ID: 23828036
[TBL] [Abstract][Full Text] [Related]
38. Local mesenchymal stem/progenitor cells are a preferential target for initiation of adult soft tissue sarcomas associated with p53 and Rb deficiency.
Choi J; Curtis SJ; Roy DM; Flesken-Nikitin A; Nikitin AY
Am J Pathol; 2010 Nov; 177(5):2645-58. PubMed ID: 20864684
[TBL] [Abstract][Full Text] [Related]
39. Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase.
Araki K; Araki M; Miyazaki J; Vassalli P
Proc Natl Acad Sci U S A; 1995 Jan; 92(1):160-4. PubMed ID: 7816809
[TBL] [Abstract][Full Text] [Related]
40. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
